Rość D - Search Results

1

Plasma HGF concentration in patients with brain tumors.

Siedlecki Z, Grzyb S, Rość D, Śniegocki M. Siedlecki Z, et al. Among authors: rosc d. AIMS Neurosci. 2020 Apr 30;7(2):107-119. doi: 10.3934/Neuroscience.2020008. eCollection 2020. AIMS Neurosci. 2020. PMID: 32607415 Free PMC article.

2

[Tissue plasminogen activator (T-PA) and tissue plasminogen activator inhibitor (PAI-1) in patients after head injury].

Beuth W, Kotschy M, Kasprzak HA, Rość D, Osiński P, Sniegocki M. Beuth W, et al. Among authors: rosc d. Neurol Neurochir Pol. 1996 May-Jun;30(3):427-34. Neurol Neurochir Pol. 1996. PMID: 8965977 Polish.

3

[Von Willebrand factor in patients with subarachnoid hemorrhage].

Beuth W, Kasprzak H, Woźniak B, Kulwas A, Kotschy M, Rość D, Sniegocki M. Beuth W, et al. Among authors: rosc d. Neurol Neurochir Pol. 2001;35 Suppl 5:130-4. Neurol Neurochir Pol. 2001. PMID: 11935674 Polish.

4

Serum VEGF-A concentrations in patients with central nervous system (CNS) tumors.

Nowacka A, Smuczyński W, Rość D, Woźniak-Dąbrowska K, Śniegocki M. Nowacka A, et al. Among authors: rosc d. PLoS One. 2018 Mar 28;13(3):e0192395. doi: 10.1371/journal.pone.0192395. eCollection 2018. PLoS One. 2018. PMID: 29590109 Free PMC article.

5

The influence of selected demographic factors and wound location on the concentration of vascular endothelial growth factor (VEGF-A) in the wound healing process after neurosurgery: brief report.

Slusarz R, Gadomska G, Biercewicz M, Grzelak L, Szewczyk MT, Rość D, Beuth W. Slusarz R, et al. Among authors: rosc d. Wound Repair Regen. 2012 Sep-Oct;20(5):667-75. doi: 10.1111/j.1524-475X.2012.00821.x. Wound Repair Regen. 2012. PMID: 22985038

6

Selected angiogenic factors in plasma of patients with lower limb symptomatic peripheral arterial disease: preliminary report.

Wieczór R, Gadomska G, Góralczyk B, Stankowska K, Budzyński J, Fabisiak J, Suppan K, Pulkowski G, Rość D. Wieczór R, et al. Among authors: rosc d. Int Angiol. 2015 Dec;34(6):545-51. Epub 2014 Nov 14. Int Angiol. 2015. PMID: 25394959

7

Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease.

Wieczór R, Gadomska G, Ruszkowska-Ciastek B, Stankowska K, Budzyński J, Fabisiak J, Suppan K, Pulkowski G, Rość D. Wieczór R, et al. Among authors: rosc d. J Zhejiang Univ Sci B. 2015 Nov;16(11):948-56. doi: 10.1631/jzus.B1500076. J Zhejiang Univ Sci B. 2015. PMID: 26537213 Free PMC article.

8

Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia.

Wieczór R, Wieczór AM, Gadomska G, Stankowska K, Fabisiak J, Suppan K, Pulkowski G, Budzyński J, Rość D. Wieczór R, et al. Among authors: rosc d. J Zhejiang Univ Sci B. 2016 Nov.;17(11):842-849. doi: 10.1631/jzus.B1600009. J Zhejiang Univ Sci B. 2016. PMID: 27819131 Free PMC article.

9

A preliminary estimation of tissue factor pathway inhibitor (TFPI) and protein C in patients with intracranial tumors.

Rość D, Grabarczyk E, Bierwagen M, Wierciński M, Góralczyk K, Haor B, Ruszkowska-Ciastek B. Rość D, et al. Adv Clin Exp Med. 2017 Nov;26(8):1219-1224. doi: 10.17219/acem/67760. Adv Clin Exp Med. 2017. PMID: 29264878 Free article.

10

Elevated plasma levels of tissue factor as a valuable diagnostic biomarker with relevant efficacy for prediction of breast cancer morbidity.

Zarychta E, Rhone P, Bielawski K, Rosc D, Szot K, Zdunska M, Ruszkowska-Ciastek B. Zarychta E, et al. Among authors: rosc d. J Physiol Pharmacol. 2018 Dec;69(6). doi: 10.26402/jpp.2018.6.06. Epub 2019 Feb 21. J Physiol Pharmacol. 2018. PMID: 30802214 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page